Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine by Brøsen K, Zeugin T, Meyer U A in Clinical pharmacology and therapeutics (1991).

[PMID: 2060250] PubMed

Abstract

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.